C ation-selective transient receptor potential (TRP) channels play important roles in numerous physiological processes and are known as polymodal sensors that integrate a wide range of physical and chemical stimuli in cellular signaling 1 . TRPV3, a representative of the vanilloid subfamily of TRP channels 2-4 , is predominantly expressed in skin keratinocytes and is implicated in cutaneous sensation including thermal sensation, nociception, and itch, in addition to maintenance of the skin barrier, wound healing, and hair growth 3,5-7 .
C ation-selective transient receptor potential (TRP) channels play important roles in numerous physiological processes and are known as polymodal sensors that integrate a wide range of physical and chemical stimuli in cellular signaling 1 . TRPV3, a representative of the vanilloid subfamily of TRP channels [2] [3] [4] , is predominantly expressed in skin keratinocytes and is implicated in cutaneous sensation including thermal sensation, nociception, and itch, in addition to maintenance of the skin barrier, wound healing, and hair growth 3, [5] [6] [7] .
The amino acid sequence of TRPV3 is ~30-40% similar to other temperature-sensitive vanilloid subtype TRP channels: TRPV1, 2, and 4. In contrast to TRPV1 and TRPV2, which are activated by noxious heat (> 40 °C), TRPV3 is activated at innocuous temperatures (~33 °C) 2, 4, 8, 9 , similar to TRPV4. TRPV3 is also activated by natural compounds such as camphor, carvacrol, eugenol, and thymol, as well as by the small synthetic compound 2-aminoethoxydiphenyl borate (2-APB) [10] [11] [12] [13] [14] [15] [16] , which has recently been shown to suppress tumor growth and invasiveness 17 . Electrophysiological studies have demonstrated that 2-APB can regulate numerous TRP channels; 2-APB activates TRPV1, TRPV3, TRPA1, TRPM6, a TRPM2-like ion channel from Nematostella vectensis [18] [19] [20] [21] , and inhibits TRPV6, TRPM7, TRPM2, TRPC3, TRPC6, and TRPC7 [22] [23] [24] [25] . TRPV3 is inhibited by the lipid phosphatidylinositol 4,5-bisphosphate, an important regulatory lipid present in the cell membrane, which also inhibits the closely related ion channels TRPV1 and TRPV2 26, 27 , activates TRPV5 and TRPV6, and facilitates the activation of TRPV4 [28] [29] [30] . Unlike TRPV1, 2, and 4, which all desensitize on successive heat or agonist applications, TRPV3 undergoes sensitization 14, 15 , which is a property that has been attributed to the reduced Ca 2+ -dependent inactivation of TRPV3 31 .
The dysfunction of TRPV3 channels, often a result of genetic mutations, is associated with numerous human skin diseases including a genodermatosis known as Olmsted syndrome, atopic dermatitis, and rosacea 32, 33 . Furthermore, overexpression of TRPV3 is implicated in the development and progression of colorectal and lung cancer 34 . Therefore, TRPV3 represents an important therapeutic target for the treatment of a variety of devastating diseases 12, 16 . Indeed, GRC 15300, a small molecule inhibitor of TRPV3, is in clinical trials as an analgesic drug 35, 36 . However, efforts to better understand the role of TRPV3 in physiology and disease, and to target this ion channel with informed drug design, are hampered by a lack of TRPV3 structural data.
Here, we determine cryo-electron microscopy (cryo-EM) structures of the full-length mouse TRPV3 in the closed apo state and in an open state bound to the agonist 2-APB. Together, these structures shed light on the functional architecture of TRPV3 and its gating mechanism. More specifically, the mechanism by which a ligand can regulate the gating state of TRPV3 is markedly different from similar processes in the closely related ion channels TRPV1 and TRPV6.
Results
Closed apo state structure. We used fluorescence-detection sizeexclusion chromatography 37 to screen different TRPV3 orthologues and found mouse TRPV3 to be a promising target for our cryo-EM structural studies. We expressed full-length TRPV3 channels in HEK 293S cells lacking N-acetyl-glucosaminyltransferase I (GnTI) and confirmed their function by Fura-2 acetoxymethyl (AM) esterbased measurements of changes in intracellular Ca 2+ in response to the application of an agonist, 2-APB ( Supplementary Fig. 1a ).
First, we determined the structure of TRPV3 without the addition of a ligand. The resulting apo state cryo-EM reconstruction, refined in fourfold rotational (C4) symmetry to an overall resolution of 4.3 Å ( Fig. 1 and Table 1 ), exhibited a higher local resolution in the core of the channel (~2.7 Å) when compared to its periphery ( Supplementary Fig. 2 ). Our cryo-EM maps ( Supplementary Fig. 3 ) allowed for the building of an accurate model of the TRPV3 homotetramer (residues 115-756), guided by a high-resolution structure of the isolated TRPV3 ankyrin repeat domain (ARD) 38 and by cryo-EM reconstructions of TRPV1, 2, 4, and 6 [39] [40] [41] [42] . The overall TRPV3 architecture ( Fig. 1a ,b,d,e) is reminiscent of other TRPV channels [39] [40] [41] [42] [43] [44] domain (TMD), which is composed of the S1-S4 and pore domains in a domain-swapped arrangement, and a large intracellular skirt domain that is primarily assembled of ARDs and encloses a large cytoplasmic cavity. Each ARD is connected to the TMD by a linker domain. Amphipathic TRP helices run nearly parallel to the membrane and interact with both the skirt and the TMD. A comparison of TRPV3 with other members of the TRPV subfamily highlights similarities and differences in their respective TMDs and ARDs ( Supplementary Fig. 4 ).
Domain assembly and lipid-like densities.
Following the C-terminal β 3 strand of the three-stranded β -sheet, the TRPV3 polypeptide forms a C-terminal loop domain that has not been observed in other TRPV channels. It includes 19 well-resolved residues (residues 737-756) that share low (< 10%) sequence identity with other TRPV channels ( Supplementary Fig. 5 ). The newly identified C-terminal loop domain extends along the corners of the TRPV3 intracellular skirt and forms an extensive network of interactions with ankyrin repeats 2-5 of the ARD (Fig. 1d-f ). Two robust nonprotein densities, presumably representing lipids, are observed in each subunit of the TRPV3 tetramer ( Fig. 1a-e ). The first density is sandwiched between the extracellular half of S4 of one subunit and the pore domain of the adjacent subunit ( Fig. 1c ). Notably, this lipid binding site is analogous to the finger 1 binding site of the double-knot toxin in TRPV1 39 and has not been observed in other TRP channel structures. The second density is in a pocket formed by the intracellular half of the S1-S4 domain and the C-terminal portion of the TRP domain ( Fig. 1c ). An analogous pocket harbors putative lipids in other TRPV channels [39] [40] [41] 43 , 2-APB in TRPV6 25 or menthol in TRPM8 45 . Importantly, a lipid occupying site 1 would interact with the pore residues N647 and L657, which have been implicated in TRPV3 activation by temperature 46 . Thus, the site 1 lipid might be involved in TRPV3 gating and in its thermoregulation in particular.
Closed pore of TRPV3. Similar to other tetrameric ion channels, the permeation pathway of TRPV3 is lined by the S6 helices and the extended portions of the pore loops (P-loops). A calculation of the radius of the TRPV3 pore in the apo state ( Fig. 2a,b ) demonstrated that the narrowest pore constriction is formed by S6 methionines (M677), which project their side chains toward the center of the permeation pathway and form a hydrophobic seal. We conclude that M677 forms the intracellular gate and that the apo state structure represents the closed nonconducting conformation of TRPV3. Indeed, the interatomic radius at the intracellular gate of TRPV3 (5.5 Å) is comparable to the corresponding radii in the closed state structures of other members of the TRPV subfamily. Similar to TRPV3, the intracellular gate is formed by methionine residues in TRPV2 40, 44 (M643), TRPV4 42 (M714), TRPV5 (M578) 43 , and TRPV6 (M577) 47 . The corresponding methionine in TRPV1 is pointing away from the pore axis and the intracellular gate is formed by I679 39, 48 .
The ion conduction pathway of TRPV3 in the closed state exhibits striking polarity; the outer pore module, including the selectivity filter, is lined exclusively by hydrophilic residues and backbone carbonyls, while the inner pore, including the central cavity and the intracellular gate region, is lined entirely by hydrophobic residues (Fig. 2a,c) . The intracellular mouth of the TRPV3 pore is lined by a pair of negatively charged residues, E679 and E682, which were both shown to be important for intracellular Mg 2+ block 49 . The selectivity filter of TRPV3 is defined by the residues 638 GLGD 641 in the P-loop extended region. The backbone carbonyl of L639 forms the selectivity filter's narrowest constriction (7.5 Å) in the closed state ( Fig. 2a,b ). This constriction is comparable to that of TRPV1 in an open state 48 (7.6 Å, formed by the G643 backbone carbonyls), but significantly larger than that of TRPV1 in the closed state (4.8 Å, formed by the G643 backbone carbonyls), TRPV2 40 (5.2 Å, formed by the G604 backbone carbonyls) and TRPV6 47 (4.2 Å, formed by the D541 side chains). The wide selectivity filter of TRPV3 in the closed state, which has a negatively charged surface, is large enough to permeate hydrated Na + , K + , or Ca 2+ ions and suggests the absence of an upper gate. Therefore, the TRPV3 gating mechanism starkly contrasts that of TRPV1, which has been shown to have two, upper and lower, gates 39, 48 .
TRPV3 structure in complex with 2-APB.
To determine the open state structure, we purified wild-type TRPV3 in the presence of the agonist 2-APB. Surprisingly, the resulting cryo-EM reconstruction was identical to the apo state reconstruction ( Supplementary Fig. 6 , Table 1 ), suggesting that 2-APB did not open the ion channel. To shift the TRPV3 gating equilibrium toward the open state, we made a substitution of a conserved tyrosine (Y564A, Supplementary  Fig. 5 ) in lipid binding site 2 that increases the apparent affinity of 2-APB ~20-fold 25 ( Supplementary Fig. 1b,d) . The resulting cryo-EM reconstruction of TRPV3(Y564A) 2-APB ( Supplementary Fig. 7 , Table 1 ) was significantly different from the closed state reconstructions ( Supplementary Fig. 6 ) and contained three strong nonprotein densities per subunit (Fig. 3a,b) . One density was observed in the same pocket as putative lipid density 2 in the closed state structure (cf. Figs. 1 and 3) . We hypothesize that this site 2 density in TRPV3(Y564A) 2-APB represents a molecule of 2-APB. Indeed, this site harbors the Y564A mutation, which increases the potency of 2-APB ( Supplementary Fig. 1) ; it binds 2-APB in the analogous site in TRPV6 25 , and the shape of TRPV3(Y564A) 2-APB density 2 matches 2-APB. Correspondingly, the chemical environment of site 2 supports the binding of 2-APB ( Fig. 3c) ; S444 of S1 interacts with the boron atom of 2-APB; and E501 of S2 and Y565 of S3 form polar interactions with the 2-APB central oxygen atom and the 2-APB tail amino group, respectively. Additionally, one of the two phenyl rings of 2-APB interacts with the imidazole group of H523 and with F526 of S3, while the other ring stacks hydrophobically with W493 of S2. The density in site 3 is located at the nexus of the linker domain, pre-S1 helix, and TRP domain, and also matches the shape of 2-APB ( Fig. 3d ). Binding of 2-APB to this site is supported by a previous mutagenesis-based study 50 . Indeed, the H426A mutation in site 3 completely eliminates TRPV3 activation by 2-APB but not by camphor ( Supplementary Fig. 1c,d) . Despite the drastic effect of the H426A mutation, binding of 2-APB to site 3 might not be the only requirement for TRPV3 activation by 2-APB. The Y564A mutation in site 2 restored activation of the H426A mutant and nearly completely recovered its apparent affinity for 2-APB ( Supplementary  Fig. 1d ). At site 3, 2-APB binding is mediated primarily by polar residues, including H417 and T421 of the linker domain, H426 and H430 of the pre-S1 helix, and R693 and R696 of the TRP domain (Fig. 3d) . The density at site 4 is nested in a cavity formed by the extracellular portions of helices S1-S4 ( Fig. 3e) , which in the closed state TRPV3 structure is occupied by the S1-S2 loop ( Supplementary Fig. 8a,b ). 2-APB binding at site 4 is mediated by both hydrophobic and hydrophilic residues including V458, Y540, R487, and Q483. Alanine substitutions of Y540, R487, or Q483 result in rightward-shifted dose-response curves for TRPV3 activation by 2-APB ( Supplementary Fig. 1d ), supporting the role of these residues in 2-APB binding. Notably, all three putative 2-APB binding sites in TRPV3(Y564A) 2-APB are distinct from the binding site at the S4-S5 interface that binds an activating lipid in TRPV6 41 , agonists such as resiniferatoxin and capsaicin, and antagonists such as capsazepine in TRPV1 39 , and the inhibitor econazole in TRPV5 51 .
Ion-conducting pore in the open state.
A calculation of the pore radius confirmed that the TRPV3(Y564A) 2-APB pore is wide-open for conducting hydrated ions (Fig. 4) . The entire ion conduction pathway is lined by polar or negatively charged side chains, or backbone carbonyls (Fig. 4a) , and it has an overall negative surface charge (Fig. 4c) , which is probably critical for the cation selectivity of TRPV3. The pore's most narrow constrictions at the gate region are defined by the side chains of E682 (interatomic distance of 8.2 Å) and I674 (interatomic distance of 8.7 Å). Despite their hydrophobic character, the I674 side chains do not introduce strong changes in the overall negatively charged surface of the pore (Fig. 4c ) and constrict the pore to a similar extent as the residues forming the narrowest pore constriction at the intracellular gate region of open TRPV1 48 (interatomic distance of 9.3 Å, measured between the side chains of I679) and TRPV6 41 (interatomic distance of 9.6 Å, measured between the side chains of I575). The diameter of the narrowest constriction in the selectivity filter (7.5 Å) is defined by the backbone carbonyl of G638. Although the narrowest constriction in the closed state is formed by the backbone carbonyl of a different residue (L639), its diameter is almost identical to the constriction in the open state (Fig. 4b) , supporting the idea that this region of the TRPV3 pore does not form a gate and functions primarily to support ion selectivity and conductance.
Conformational changes in the pore during gating. Superposition of the closed and open TRPV3 structures reveals pronounced conformational changes in the pore-forming region (Fig. 5 ). For instance, with channel opening, the pore helices tilt by 7° and their C-terminal ends, which point toward the center of the pore, move down by ~5 Å (Fig. 5a ). The rearrangement in the upper pore results in different residues contributing their backbone carbonyls to the selectivity filter's narrowest constriction in the closed (L639) and open (G638) states. Concurrently, each S6 helix undergoes a local α -to-π helical transition, similar to the one observed in TRPV6 41 , which originates at T665 (Fig. 5a-c) . T665 is highly conserved in TRPV1-4 and is analogous to the gating hinge alanine in TRPV6 41 and glycine in K + channels 52, 53 (Supplementary Fig. 5 ). The formation of the short π -helix results in S6 splaying away from the pore by about ~11° and an ~100° rotation of its lower portion. The rotation exposes an entirely different set of S6 residues to the pore in the open and closed states. In the closed state, these are mostly hydrophobic residues that seal the pore and form the gate (Fig. 2) . In the open state, however, these are primarily hydrophilic and negatively charged residues that promote ion permeation (Fig. 4) .
In contrast to the gating rearrangements in TRPV1 39, 48 and TRPV6 41 , the conformational changes in S6 are propagated to the TRP helix and result in dramatic overall changes in TRPV3. In the open state, the S6 helices become longer by two helical turns ( Fig. 5a-c ) and the TRP helices become two helical turns shorter while rotating ~20° in the plane of the membrane. As a result, the rest of the channel, including the S1-S4 domains and the intracellular skirt, rotate around the pore domain and the channel becomes ~5 Å shorter when opening (Fig. 6a,b ). Such pronounced structural rearrangements have not been observed during activation of TRPV1 (Fig. 6c,d) or TRPV6 (Fig. 6e,f) and emphasize the substantially different gating mechanism of TRPV3. The rotation of the S1-S4 domain, with respect to the pore domain, reduces the distance between the extracellular halves of S4 and S6 of the neighboring subunit (Figs. 5d,e and 6a ) and expels the lipid from site 1, which is only present in the closed state (Fig. 1 ). This lipid expulsion is consistent with previous observations that lipids can stabilize the resting state of TRPV3 and that transitioning from a closed to an open state can be accompanied by changes in lipid binding 13 .
Discussion
By comparing the putative 2-APB binding sites 2 and 3 in the open and closed state structures of TRPV3, we discovered that they are almost identical and do not exhibit strong gating-associated conformational changes ( Supplementary Fig. 8c ). In contrast, dramatic structural rearrangements are observed at site 4 (Fig. 7a ). We hypothesize that 2-APB binds at site 4, where it outcompetes the S1-S2 loop ( Supplementary Fig. 8a,b ). This binding seems to be important for channel opening, because the closed state structure of TRPV3 2-APB has 2-APB molecules at sites 2 and 3 but not at site 4. As a result of 2-APB binding to site 4, the top of the S1-S4 bundle expands, the cleft between S4 and the neighboring S6 narrows, the lipid is squeezed out of site 1, and the S1-S4 and pore domain interface rearranges in a manner that supports channel opening (Fig. 7b ). Binding of 2-APB to sites 2 and 3 is probably necessary for the relative stability of the pore, and the S1-S4 and skirt domains during channel opening; therefore, it is a prerequisite for gating ( Supplementary Fig. 1 ). Similarly to TRPV6, two highly conserved residues in S5 (D586) and S6 (T680) form a hydrogen bond that stabilizes the open state ( Fig. 7a ). Further studies are necessary to decipher the energetics and domain dynamics during TRPV3 gating. Therefore, the open and closed structures of TRPV3 presented here can serve as a spring board for such studies as well as templates for the design of drugs targeting inflammatory skin conditions, itch, pain, and cancer.
URLs. Leginon, http://emg.nysbc.org/redmine/projects/leginon/ wiki/Leginon_Homepage. In the closed state (left), a lipid (purple) is bound between the S1-S4 (beige) and pore (light blue) domains and the pocket at the top of the S1-S4 domain is occupied by the S1-S2 loop. In the open state (right), 2-APB (light green triangle) binds to and expands the top of the S1-S4 domain, squeezes out the lipid, and brings the S1-S4 and pore domains closer together. As a result, the S1-S4-pore domain interface rearranges and S5 and S6 move away from the pore, opening it for permeation of ions (dark green).
